Short-Term (1–2 years): I think a reasonable target is around $1.50–2.00, assuming things go well — not super aggressive, but achievable if Morpho keeps executing.
Medium to Long-Term (3–5 years): If Morpho scales well and captures real institutional or retail lending demand, $6–9 is plausible, but it’s on the more bullish side.
High Risk Reward: MORPHO has real upside, but it's not a “safe bet”; there's meaningful risk too.
